Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records
Fiche du document
28 novembre 2023
- handle: 10670/1.4cp9nq
- hal: hal-04461501
- doi: 10.1186/s12933-023-02069-y
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-02069-y
http://creativecommons.org/licenses/by/ , info:eu-repo/semantics/OpenAccess
Mots-clés
I - Health, Education, and Welfare/I.I1 - Health/I.I1.I18 - Government Policy • Regulation • Public Health -bio]/Santé publique et épidémiologie -bio]/Human health and pathology/Cardiology and cardiovascular system -bio]/Human health and pathology/Endocrinology and metabolismSujets proches
Natural science Sciences Science of science Wellness Personal health Biography--HealthCiter ce document
Kamel Mohammedi et al., « Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records », HAL-SHS : économie et finance, ID : 10.1186/s12933-023-02069-y
Métriques
Partage / Export
Résumé
International audience